Format

Send to

Choose Destination
See comment in PubMed Commons below
Vaccine. 2013 Oct 1;31(42):4902-10. doi: 10.1016/j.vaccine.2013.07.014. Epub 2013 Jul 16.

Public finance of rotavirus vaccination in India and Ethiopia: an extended cost-effectiveness analysis.

Author information

1
Department of Global Health, University of Washington, Seattle, WA, United States. Electronic address: verguet@uw.edu.

Abstract

BACKGROUND:

An estimated 4% of global child deaths (approximately 300,000 deaths) were attributed to rotavirus in 2010. About a third of these deaths occurred in India and Ethiopia. Public finance of rotavirus vaccination in these two countries could substantially decrease child mortality and also reduce rotavirus-related hospitalizations, prevent health-related impoverishment and bring significant cost savings to households.

METHODS:

We use a methodology of 'extended cost-effectiveness analysis' (ECEA) to evaluate a hypothetical publicly financed program for rotavirus vaccination in India and Ethiopia. We measure program impact along four dimensions: 1) rotavirus deaths averted; 2) household expenditures averted; 3) financial risk protection afforded; 4) distributional consequences across the wealth strata of the country populations.

RESULTS:

In India and Ethiopia, the program would lead to a substantial decrease in rotavirus deaths, mainly among the poorer; it would reduce household expenditures across all income groups and it would effectively provide financial risk protection, mostly concentrated among the poorest. Potential indirect benefits of vaccination (herd immunity) would increase program benefits among all income groups, whereas potentially decreased vaccine efficacy among poorer households would reduce the equity benefits of the program.

CONCLUSIONS:

Our approach incorporates financial risk protection and distributional consequences into the systematic economic evaluation of vaccine policy, illustrated here with the case study of public finance for rotavirus vaccination. This enables selection of vaccine packages based on the quantitative inclusion of information on equity and on how much financial risk protection is being bought per dollar expenditure on vaccine policy, in addition to how much health is being bought.

KEYWORDS:

Child health; Equity; Extended cost-effectiveness analysis (ECEA); Financial risk protection; Low- and middle-income settings; Rotavirus; Vaccination

PMID:
23871824
DOI:
10.1016/j.vaccine.2013.07.014
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center